Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trypsin is a serine protease enzyme, traditionally harvested from the pancreas of bovine or porcine sources, that catalyzes the hydrolysis of peptide bonds specifically at the carboxyl side of the basic amino acids lysine and arginine. Therapeutically, trypsin is most commonly employed as a topical debriding agent to treat decubitus ulcers, pressure sores, and other necrotic wounds; it facilitates the removal of devitalized tissue and purulent exudate by liquefying proteinaceous debris. In the context of pancreatic disorders, trypsin is a critical component of pancrelipase (pancreatin) used for enzyme replacement therapy in patients with pancreatic exocrine insufficiency resulting from chronic pancreatitis or cystic fibrosis. Additionally, oral formulations of trypsin, often in combination with chymotrypsin, are used in certain jurisdictions to manage inflammation and edema following trauma or surgical procedures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on trypsin.